Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Bioactivation, reductive

Redox conditions Conditions defined by the presence of either dissolved oxygen or some other species capable of providing oxygen bioactivity (reduction—oxidation). [Pg.377]

The last reaction perhaps involves an intermediate such as 33a which expells a proton and dimethyl sulfide. Formation of the Schiff s base with t-butylamine, reduction with sodium borohydride and hydrogenolysis of the benzyl ether produces sulfonterol (28). Despite the fact that the methylene hydrogen of sulfonterol must be much less acidic than of the corresponding urea proton on carbuterol or the sulfonamide proton on soterenol, good bioactivity is retained. [Pg.43]

Deprotection of X, and subsequent oxidation, reduction, and acetylation reactions can, with care, be carried out without decomposition of the inorganic backbone. Reactions of this type are of particular interest for the synthesis of bioactive or biocompatible polyphosphazenes. [Pg.257]

The use of periodate as a cleavage agent does have advantages, however. Unlike the use of cleavable crosslinkers that contain disulfide bonds which require a reductant to break the conjugate, cleavage of diol-containing crosslinks with periodate typically preserves the indigenous disulfide bonds and tertiary structure of proteins and other molecules. As a result, with most proteins bioactivity usually remains unaffected after mild periodate treatment. [Pg.393]

Recently, a novel method of Hb immobilization was achieved by Lu [120], The direct electrochemistry of Hb was successfully achieved by adsorbed Hb onto the surface of a yeast cell through electrostatic attractions on a GC electrode. The bioactivity of Hb immobilized in yeast cell film was retained, and the catalytic reduction of NO and H202 was estimated. [Pg.565]

The relationship between the herbicidal activity of 1,2,5-oxadiazole iV-oxides and some physicochemical properties potentially related to this bioactivity, such as polarity, molecular volume, proton acceptor ability, lipophilicity, and reduction potential, were studied. The semi-empirical MO method AMI was used to calculate theoretical descriptors such as dipolar moment, molecular volume, Mulliken s charge, and the octanol/water partition coefficients (log Po/w) <2005MOL1197>. [Pg.319]

Fresh cut fruits are cut in a wide variety of shapes, and the cutting shapes could influence the degree of damage caused by the wound (Rivera-Lopez and others 2005). Minimal processing includes the unit operation of size reduction, and a given shape has to be given to the product depending on its final use. In the next section the effect of this unit operation on phytochemical constituents and bioactivity is discussed. [Pg.318]

By definition, a nutraceutical (derived from the term nutritional pharmaceutical ) is a foodstuff (fortified food or dietary supplement) that is held to provide health or medical benefits in addition to its basic nutritional value [1], Nutraceuticals derived from botanicals deliver a concentrated form of presumed bioactive agents from plants that are not generally part of the food supply. The term nutraceutical has no regulatory definition. Similarly, functional foods, as defined by the International Life Sciences Institute (ILSI), are foods that by virtue of physiologically active food components, provide health benefits beyond basic nutrition [2], For the purposes of this review, these two terms will be differentiated by the form in which they are consumed. Nutraceuticals refers to dietary supplements most often found in pill or capsule form functional foods are ingested as part of a normal food pattern. Both are intended to provide beneficial effects beyond their nutritional value, and contribute to an improved state of health and/or reduction of risk of disease. [Pg.186]

The enantioselective reduction of unsaturated alcohol derivatives has been applied to the synthesis of several biologically active compounds (Scheme 24.12). Warfarin (123, R=H) is an important anticoagulant that is normally prescribed as the racemate, despite the enantiomers having dissimilar pharmacological profiles. One of the earliest reported uses of DuPhos was in the development of a chiral switch for this bioactive molecule, facilitating the preparation of (R)- and (S)-warfarin [184]. Although attempted reduction of the parent hydroxycoumarin 122 (R=H) led to formation of an unreactive cyclic hemiketal, hydrogenation of the sodium salt proceeded smoothly with Rh-Et-DuPhos in 86-89% ee. [Pg.818]

Tolerance to nitrates is defined as the reduction in hemodynamic effect or the requirement for higher doses to achieve a persistent effect with continuous use in the face of constant plasma concentrations [15]. Nitrate tolerance was first described for nitroglycerin in 1888 [36] it occurs with all organic nitrates, albeit to different extents. For reasons that are not understood, PETN appears to be the least susceptible to the development of tolerance. No, or much less, tolerance is observed with nitrite esters, such as amyl nitrite [37], molsidomine, and sodium nitroprusside. Earlier investigations suggested that a depletion of intracellular thiols is involved in tolerance development [17], but this has not been substantiated in later studies [38, 39]. As with organic nitrate bioactivation, the precise mechanism(s) involved in nitrate tolerance remain(s) unknown, but it is likely to be complex and multifactorial. Two principal... [Pg.293]

FIGURE 5.12 Bioactivation of mitomycin C, the first step of which involves reduction of the quinone. [Pg.117]

While common biosynthetic pathways may provide the framework for the various classes of secondary metabolites, their functionality is imparted by specialized tailoring enzymes that are often unique to natural products (Walsh 2004 Hertweck et al. 2007). Whether it is the addition of alcohol groups, halogenation (Gribble 1998), oxidation, reduction, stereochemical manipulation, or cyclization, it is often these functionalities that make secondary metabolites unique and bioactive. [Pg.8]


See other pages where Bioactivation, reductive is mentioned: [Pg.117]    [Pg.117]    [Pg.117]    [Pg.117]    [Pg.175]    [Pg.176]    [Pg.348]    [Pg.348]    [Pg.204]    [Pg.355]    [Pg.427]    [Pg.131]    [Pg.214]    [Pg.13]    [Pg.210]    [Pg.214]    [Pg.339]    [Pg.142]    [Pg.64]    [Pg.571]    [Pg.132]    [Pg.149]    [Pg.14]    [Pg.279]    [Pg.332]    [Pg.7]    [Pg.324]    [Pg.53]    [Pg.114]    [Pg.515]    [Pg.43]    [Pg.44]    [Pg.45]    [Pg.97]    [Pg.339]    [Pg.521]    [Pg.938]    [Pg.99]   
See also in sourсe #XX -- [ Pg.488 ]




SEARCH



Bioactivation reduction reactions

Prodrugs reductive bioactivations

Reduction bioactivation

Reduction bioactivation

Reductive bioactivations

Reductive bioactivations

© 2024 chempedia.info